Cargando…

Long‐term administration of intravenous inotropes in advanced heart failure

BACKGROUND: Patients in heart transplantation (HTx) waiting list for advanced heart failure (HF) are susceptible to acute deterioration refractory to standard HF medical therapies. Limited data are available on long‐term in‐hospital continuous intravenous (IV) inotropic therapy as bridge to definite...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gentile, Piero, Marini, Claudia, Ammirati, Enrico, Perna, Enrico, Saponara, Gianluigi, Garascia, Andrea, D'Angelo, Luciana, Verde, Alessandro, Foti, Grazia, Masciocco, Gabriella, Frigerio, Maria, Cipriani, Manlio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497373/ https://www.ncbi.nlm.nih.gov/pubmed/34191408 http://dx.doi.org/10.1002/ehf2.13394

Ejemplares similares

Haemodynamic effects of sacubitril/valsartan in advanced heart failure
por: Gentile, Piero, et al.
Publicado: (2022)

Update on acute myocarditis
por: Ammirati, Enrico, et al.
Publicado: (2020)

Fulminant myocarditis: Characteristics, treatment, and outcomes
por: Veronese, Giacomo, et al.
Publicado: (2018)

Antithrombotic therapy in ventricular assist device (VAD) management: From ancient beliefs to updated evidence. A narrative review()
por: Morici, Nuccia, et al.
Publicado: (2018)

Takotsubo syndrome after BNT162b2 mRNA Covid-19 vaccine: Emotional or causative relationship with vaccination?
por: Tedeschi, Andrea, et al.
Publicado: (2022)

Endothelial Dysfunction in Patients with Advanced Heart Failure Treated with Levosimendan Periodic Infusion Compared with Optimal Medical Therapy: A Pilot Study
por: Maloberti, Alessandro, et al.
Publicado: (2022)

New concepts in fulminant myocarditis and risk of cardiac mortality
por: Ammirati, Enrico, et al.
Publicado: (2017)

Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors
por: Merlo, Marco, et al.
Publicado: (2019)

Cardiogenic shock: old and new circulatory assist devices: the role of counter-pulsation
por: Viola, Giovanna, et al.
Publicado: (2019)

Vasopressor stays vasopressor and inotrope stays inotrope!
por: Luckner, Günter, et al.
Publicado: (2008)

Vasopressin Is No Inotrope
por: Roeleveld, Peter Paul
Publicado: (2018)

Inotropic effects of a single intravenous recommended dose of pimobendan in healthy dogs
por: HORI, Yasutomo, et al.
Publicado: (2018)

Total inotrope exposure score: an extension of the vasoactive inotrope score
por: Bangalore, H, et al.
Publicado: (2015)

Hemodynamic effects of intravenous paracetamol in critically ill children with septic shock on inotropic support
por: Nahum, Elhanan, et al.
Publicado: (2020)

Scenarios in precision medicine: proteomics in heart failure
por: Gentile, Piero, et al.
Publicado: (2022)

Short-term treatments for acute cardiac care: inotropes and inodilators
por: Guarracino, Fabio, et al.
Publicado: (2020)

Threshold of Inotropic Score and Vasoactive–Inotropic Score for Predicting Mortality in Pediatric Septic Shock
por: Kallekkattu, Dipu, et al.
Publicado: (2021)

Inotropes and Inodilators for Acute Heart Failure: Sarcomere Active Drugs in Focus
por: Nagy, László, et al.
Publicado: (2014)

State-of-the-Art of Endomyocardial Biopsy on Acute Myocarditis and Chronic Inflammatory Cardiomyopathy
por: Ammirati, Enrico, et al.
Publicado: (2022)

Cardiac Inotropic Effect of Long-Term Administration of Oral Thymoquinone
por: Asoom, Lubna Ibrahim Al, et al.
Publicado: (2019)

Differential effects of inotropes and inodilators on renal function in acute cardiac care
por: Zima, Endre, et al.
Publicado: (2020)

Post hoc analysis of the glutamics–trial: intravenous glutamate infusion and use of inotropic drugs after cabg
por: Vidlund, Mårten, et al.
Publicado: (2016)

Comparison of myocardial T1 mapping techniques at 1.5T to detect interstitial fibrosis in patients with orthotopic cardiac transplant
por: Pedrotti, Patrizia, et al.
Publicado: (2014)

On inotropic effects of UTP in the human heart
por: Neumann, J., et al.
Publicado: (2019)

Current use of inotropes in circulatory shock
por: Scheeren, Thomas W. L., et al.
Publicado: (2021)

Heart-Kidney Transplanted patient affected by COVID-19 pneumonia treated with tocilizumab on top of immunosuppressive maintenance therapy
por: Ammirati, Enrico, et al.
Publicado: (2020)

Advanced heart failure: from definitions to therapeutic options
por: Garascia, Andrea, et al.
Publicado: (2023)

Continuous Intravenous Inotropes in Ward Units: Expanding Therapy Outside Intensive Care using a Safety-Oriented Protocol
por: Hastenteufel, Laura Caroline Tavares, et al.
Publicado: (2019)

Inotropic score and vasoactive inotropic score as predictors of outcomes in congenital diaphragmatic hernia: A single center retrospective study
por: Hari Gopal, Srirupa, et al.
Publicado: (2023)

Positive inotropic action of insulin on piglet heart.
por: Rieker, R. P., et al.
Publicado: (1975)

New arylsparteine derivatives as positive inotropic drugs
por: Boido, Vito, et al.
Publicado: (2017)

Validation of the Vasoactive-Inotropic Score in Pediatric Sepsis*
por: McIntosh, Amanda M., et al.
Publicado: (2017)

Peripheral Inotropes in Critically Ill Children: Is It Safe?
por: Mooli, Ravi K., et al.
Publicado: (2021)

Co-administration of Apelin and T4 Protects Inotropic and Chronotropic Changes Occurring in Hypothyroid Rats
por: Akhondali, Zahra, et al.
Publicado: (2015)

Efficacy of intravenous immunoglobulin (IVIg) on COVID-19-related neurological disorders over the last 2 years: an up-to-date narrative review
por: Manganotti, Paolo, et al.
Publicado: (2023)

The Mortality Benefit of Milrinone as a Continuous Outpatient Intravenous Inotrope Therapy in Advanced Heart Failure: A Systemic Review and Meta-Analysis
por: Del Rio-Pertuz, Gaspar, et al.
Publicado: (2023)

A STUDY OF INOTROPIC MECHANISMS IN THE PAPILLARY MUSCLE PREPARATION
por: Abbott, B. C., et al.
Publicado: (1959)

Corticosteroids reduce inotrope requirements in hypotensive liver failure
por: Harry, R, et al.
Publicado: (2001)

Inotropes do not increase mortality in advanced heart failure
por: Guglin, Maya, et al.
Publicado: (2014)

Use of Inotropic Agents in Treatment of Systolic Heart Failure
por: Tariq, Sohaib, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_90pq8im06tep1j4ddgb75qe3hp